Cardiff Oncology, Inc. (FRA:XE7C)
Germany flag Germany · Delayed Price · Currency is EUR
1.750
+0.076 (4.54%)
At close: Dec 4, 2025

Cardiff Oncology Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
1222796059222520
Upgrade
Market Cap Growth
-3.44%366.18%2.21%-73.61%-57.31%5972.61%
Upgrade
Enterprise Value
71225-12-46107491
Upgrade
Last Close Price
1.774.051.271.255.1513.90
Upgrade
PS Ratio
286.12422.72135.50162.04702.511736.31
Upgrade
PB Ratio
2.943.480.950.591.804.96
Upgrade
P/TBV Ratio
2.943.480.950.591.804.96
Upgrade
EV/Sales Ratio
164.77340.75--338.281640.66
Upgrade
Debt / Equity Ratio
0.020.020.030.030.020.01
Upgrade
Asset Turnover
0.010.010.010.000.000.01
Upgrade
Quick Ratio
4.146.927.2513.5821.5521.46
Upgrade
Current Ratio
4.207.087.4214.2522.2821.79
Upgrade
Return on Equity (ROE)
-102.71%-59.51%-47.07%-31.37%-21.07%-28.50%
Upgrade
Return on Assets (ROA)
-52.99%-34.01%-28.69%-18.77%-12.69%-16.14%
Upgrade
Return on Capital (ROIC)
-66.55%-38.89%-31.37%-19.75%-13.23%-17.28%
Upgrade
Return on Capital Employed (ROCE)
-109.40%-58.10%-63.80%-36.80%-20.20%-14.80%
Upgrade
Earnings Yield
-35.19%-15.74%-62.67%-61.88%-11.22%-3.04%
Upgrade
FCF Yield
-29.49%-13.08%-47.59%-55.68%-9.22%-2.60%
Upgrade
Buyback Yield / Dilution
-40.37%-6.65%-2.47%-11.71%-86.97%-249.44%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.